Focus on a fabless, R&D-driven business model
First written in FY2016. 21 of 35 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026Annual R&D expenses of ¥1,641 million, up 6.0% year on yearAnnual report
「In addition, R&D expenses included in selling, general and administrative expenses were ¥1,641 million, an increase of ¥93 million, or 6.0%.」
Although there were no material changes in the policy for its R&D activities, annual R&D expenses were ¥1,641 million, an increase of 6.0% from the previous fiscal year. - 2026-05-11AdvancedFinancial Results Presentation
「The next-generation global standard for CPUs, “RISC-V” / One form of fully homomorphic encryption, “TFHE”」
The company has identified RISC-V and TFHE as specific areas of focus for basic research. - FY2026-H1Interim R&D expenses of ¥748 million, up 7.2% from the same interim period of the previous yearAnnual report
「R&D expenses included in selling, general and administrative expenses were ¥748 million, an increase of ¥50 million, or 7.2%, from the same interim period of the previous year. There were no material changes in the status of the Group's R&D activities during the current interim consolidated accounting period.」
While stating that there had been no material changes in the status of its R&D activities, the Company reported interim R&D expenses of ¥748 million, up 7.2% from the same interim period of the previous year. - FY2025-H1Interim R&D expenses of ¥697 million, down 10.7% from the same interim period of the previous yearAnnual report
「R&D expenses included in selling, general and administrative expenses were ¥697 million, a decrease of ¥83 million, or 10.7%, from the same interim period of the previous year.」
While stating that there had been no material changes in the status of its R&D activities, the Company disclosed R&D expenses of ¥697 million for the current interim consolidated accounting period. - FY2024Disclosed full-year R&D expenses of ¥1,579 millionAnnual report
「Total R&D expenses for the fiscal year were ¥1,579 million.」
The Company maintained its R&D-focused fabless model and disclosed full-year R&D expenses of ¥1,579 million. - FY2024-Q3Disclosed third-quarter R&D expenses of ¥1,163 millionAnnual report
「R&D activities amounted to ¥1,163 million during the third quarter of the current consolidated cumulative period. There were no material changes in the status of the Group's R&D activities during the third quarter of the current consolidated cumulative period.」
While stating that there had been no material changes in its R&D activities, the Company disclosed R&D expenses of ¥1,163 million for the third quarter of the current consolidated cumulative period. - FY2024-Q2RestatedAnnual report
「R&D activities amounted to ¥781 million during the second quarter of the current consolidated cumulative period. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」
While stating that there had been no material changes in the status of its R&D activities, the Company disclosed R&D expenses of ¥781 million for the second quarter of the current cumulative period. - FY2024-Q1RestatedAnnual report
「R&D activities amounted to ¥338 million during the first quarter of the current consolidated cumulative period. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
While stating that there had been no material changes in its R&D activities, the Company disclosed R&D expenses of ¥338 million for the first quarter of the current cumulative period. - FY2023Disclosed full-year R&D expenses of ¥1,552 millionAnnual report
「Total R&D expenses for the fiscal year were ¥1,552 million.」
The Company maintained its R&D-focused fabless model and disclosed full-year R&D expenses of ¥1,552 million. - FY2023-Q3Disclosed third-quarter R&D expenses of ¥1,206 millionAnnual report
「R&D expenses included in selling, general and administrative expenses were ¥1,206 million, an increase of ¥284 million, or 30.9%, from the same quarter of the previous year.」
While stating that there had been no material changes in the status of its R&D activities, the Company disclosed R&D expenses of ¥1,206 million for the third quarter of the current consolidated cumulative period. - FY2023-Q2Disclosed second-quarter R&D expenses of ¥770 millionAnnual report
「R&D activities amounted to ¥770 million during the second quarter of the current consolidated cumulative period. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」
While stating that there had been no material changes in its R&D activities, the Company disclosed R&D expenses of ¥770 million for the second quarter of the current consolidated cumulative period. - FY2023-Q1RestatedAnnual report
「R&D expenses included in selling, general and administrative expenses were ¥456 million, an increase of ¥194 million, or 74.4%, from the same quarter of the previous year.」
R&D expenses increased to ¥456 million, but the Company was stated to have maintained its policy of operating an R&D-focused business despite no material changes in the status of its R&D activities. - FY2022RestatedAnnual report
「The Group primarily operates as a fabless manufacturer and has adopted a business model that does not require substantial capital investment in factories or other facilities.」
The Company continues to maintain its fabless business model and operate a business centered on R&D and sales. - FY2022-Q3RestatedAnnual report
「R&D expenses included in selling, general and administrative expenses were ¥921 million, a decrease of ¥169 million, or 15.5%, from the same quarter of the previous year. There were no material changes in the status of the Group's R&D activities during the third quarter of the current consolidated cumulative period.」
R&D expenses were ¥921 million, but the Company stated that there had been no material changes in the status of its R&D activities and maintained its policy of operating an R&D-focused fabless model. - FY2022-Q2RestatedAnnual report
「R&D activities amounted to ¥540 million during the second quarter of the current consolidated cumulative period. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」
R&D expenses were ¥540 million, but the Company stated that there had been no material changes in the status of its R&D activities and maintained its policy of operating an R&D-focused fabless model. - FY2022-Q1RestatedAnnual report
「R&D expenses included in selling, general and administrative expenses were ¥261 million, an increase of ¥1 million, or 0.5%, from the same quarter of the previous year.」
R&D expenses were ¥261 million, but the Company stated that there had been no material changes in the status of its R&D activities and maintained its R&D-focused fabless model. - FY2021-Q3RestatedAnnual report
「R&D expenses included in selling, general and administrative expenses were ¥1,091 million, an increase of ¥112 million, or 11.5%, from the same quarter of the previous year.」
R&D expenses were ¥1,091 million, but the Company maintained its longstanding policy of stating that there had been no material changes in the status of its R&D activities. - FY2021-Q2RestatedAnnual report
「R&D expenses included in selling, general and administrative expenses were ¥738 million, an increase of ¥63 million, or 9.5%, from the same quarter of the previous year.」
R&D expenses were ¥738 million, but the Company stated that there had been no material changes in the status of its R&D activities and maintained its R&D-focused fabless model. - FY2021-Q1RestatedAnnual report
「R&D activities amounted to ¥260 million during the first quarter of the current consolidated cumulative period. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
The Company reiterated that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥260 million for the first quarter of the current cumulative period. - FY2020RestatedAnnual report
「The Group primarily operates as a fabless manufacturer and has adopted a business model that does not require substantial capital investment in factories or other facilities.」
The Company continues to operate a fabless R&D and sales model. R&D expenses were ¥1,549 million in the fiscal year. - FY2020-Q3RestatedAnnual report
「R&D expenses for the nine months ended this third quarter were ¥978 million. There were no material changes in the status of our group's R&D activities during the nine months ended this third quarter.」
The company reiterated that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥978 million for the nine months ended the third quarter. - FY2020-Q2RestatedAnnual report
「R&D expenses for the six months ended this second quarter were ¥674 million. There were no material changes in the status of our group's R&D activities during the six months ended this second quarter.」
The company reiterated that there had been no material changes in its R&D activities and disclosed R&D expenses of ¥674 million for the six-month period. - FY2019Annual R&D spending increasedAnnual report
「Total R&D expenses for the fiscal year were ¥2,513 million.」
The company maintained its research and development-driven fabless model, and R&D expenses increased from ¥2,134 million in the previous fiscal year to ¥2,513 million. - FY2019-Q3RestatedAnnual report
「Although we worked to reduce expenses across the board, selling, general and administrative expenses increased by ¥451 million, or 19.4%, year on year to ¥2,778 million, mainly because some prototype development costs for next-generation core products were recorded. R&D expenses included in selling, general and administrative expenses increased by ¥445 million, or 26.7%, year on year to ¥2,112 million. Development costs for next-generation core products had largely run their course in the first quarter.」
While maintaining its explanation that development costs for next-generation core products had largely run their course in the first quarter, the company reported that R&D expenses increased 26.7% year on year to ¥2,112 million. - FY2019-Q2Rising R&D expenses alongside the completion of development costs for next-generation productsAnnual report
「Although we worked to reduce expenses across the board, selling, general and administrative expenses increased by ¥497 million, or 30.2%, year on year to ¥2,146 million, mainly because some prototype development costs for next-generation core products were recorded. R&D expenses included in selling, general and administrative expenses increased by ¥486 million, or 40.2%, year on year to ¥1,698 million. Development costs for next-generation core products had largely run their course in the first quarter.」
The company stated that R&D expenses increased 40.2% year on year to ¥1,698 million, while development costs for next-generation core products had largely run their course in the first quarter. - FY2019-Q1AdvancedAnnual report
「Development costs for next-generation core products had largely run their course during the first quarter, and we expect R&D expenses to trend downward from the second quarter onward.」
While there were no material changes to the research and development-driven fabless model itself, prototype development costs for next-generation core products had largely run their course in the first quarter, and R&D expenses are expected to decline from the second quarter onward. - FY2018RestatedAnnual report
「We are a research and development-driven fabless semiconductor manufacturer whose business is focused on research and development and marketing activities.」
The company continues to base its business on a fabless model focused on research and development and marketing. R&D expenses were ¥2,134 million, down 13.0% from the previous fiscal year. - FY2018-Q3RestatedAnnual report
「Selling, general and administrative expenses decreased by ¥320 million, or 12.1%, year on year to ¥2,326 million, reflecting broad-based expense reductions and a decline in R&D expenses from the same quarter of the previous year. R&D expenses included in selling, general and administrative expenses decreased by ¥249 million, or 13.0%, year on year to ¥1,666 million.」
Although R&D expenses decreased 13.0% year on year, the company explicitly stated that there had been no material changes in the status of its R&D activities, maintaining its policy of operating a research and development-driven fabless model. - FY2018-Q2RestatedAnnual report
「Selling, general and administrative expenses decreased by ¥115 million, or 6.5%, year on year to ¥1,648 million, reflecting broad-based expense reductions and a slight decline in R&D expenses from the same quarter of the previous year. R&D expenses included in selling, general and administrative expenses decreased by ¥50 million, or 4.0%, year on year to ¥1,211 million.」
R&D expenses decreased 4.0% year on year to ¥1,211 million, but the company stated that there had been no material changes in the status of its R&D activities. - FY2018-Q1RestatedAnnual report
「Although we worked to reduce expenses across the board, selling, general and administrative expenses increased by ¥73 million, or 8.7%, year on year to ¥921 million, mainly because some prototype development costs for next-generation core products were recorded. R&D expenses included in selling, general and administrative expenses increased by ¥129 million, or 22.4%, year on year to ¥705 million.」
The company recorded prototype development costs for next-generation core products and invested ¥705 million in R&D, while stating that there had been no material changes in the status of its R&D activities. - FY2017RestatedAnnual report
「We are a research and development-driven fabless semiconductor manufacturer whose business is focused on research and development and marketing activities.」
The company reaffirmed its fabless model focused on research and development and marketing. - FY2017-Q3RestatedAnnual report
「R&D expenses for the nine months ended this third quarter were ¥1,916 million. There were no material changes in the status of our R&D activities during the nine months ended this third quarter.」
The company reiterated that there had been no material changes in its R&D activities. R&D expenses were ¥1,916 million, down 10.8% year on year. - FY2017-Q2RestatedAnnual report
「Although we are making aggressive R&D investments aimed at future growth, R&D expenses for the six months ended this second quarter decreased by ¥319 million, or 20.2%, year on year to ¥1,261 million.」
The company stated that it continues to make aggressive R&D investments aimed at future growth. R&D expenses decreased 20.2% year on year to ¥1,261 million, but no change in the investment policy itself was indicated. - FY2017-Q1AdvancedAnnual report
「Selling, general and administrative expenses increased by ¥66 million, or 8.5%, year on year to ¥848 million, as a result of continued aggressive investment in research and development aimed at future growth. R&D expenses included in selling, general and administrative expenses increased by ¥77 million, or 15.5%, year on year to ¥576 million.」
The company continued aggressive R&D investment aimed at future growth, with R&D expenses increasing 15.5% year on year to ¥576 million. - FY2016First statedAnnual report
「We are a research and development-driven fabless semiconductor manufacturer whose business is focused on research and development and marketing activities.」
The company outsources manufacturing and operates a business model focused on research and development and marketing.